IP Library Granted Patent US 10,285,702
Granted Patent B2
US 10,285,702 · App. 14/785,047 · Granted May 14, 2019

Bioresorbable biopolymer anastomosis devices

Inventors: Rodrigo R. Jose (Medford, MA); Waseem K. Raja (Medford, MA); David L. Kaplan (Concord, MA); Ahmed Ibrahim (Brookline, MA); Samuel Lin (Dover, MA); Abdurrahman Abdurrob (Winchester, MA)
Assignees: Trustees of Tufts College; Beth Israel Deaconess Medical Center, Inc.
A61B17/11A61B2017/00004A61B2017/00526A61B2017/00778A61B2017/00858A61B2017/00893A61B2017/1107A61B2017/1132A61L27/502A61L27/507
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,285,702
App. No.
14/785,047
Granted
May 14, 2019
Kind
B2
Abstract

A bioresorbable drug-eluting biopolymer suture-free blood vessel anastomosis devices can be deployed to join two blood vessels and resorbed by the body over a predetermined time period after the blood vessel has become joined. The anastomosis device can include a hollow tube that is inserted interconnect the two vessels to be jointed. A non-piercing suture is wrapped around the vessel to secure the anastomosis. The anastomosis device can include hollow tube that extends along an axis from a first end to a second end. The ends can be fitted with elements that facilitate mechanical attachment of the vessel to the anastomosis device and provide for a secure seal.

Claims (26)

1. An anastomosis device for promoting vascular healing comprising:

a hollow tube that extends along a longitudinal axis from a first end to a second end,

the hollow tube comprising a blend that comprises silk fibroin and a plasticizer that is programmably biodegradable and/or resorbable, the hollow tube having a compressive strength within a range of 1 MPa to 10 MPa,

wherein an outside diameter of the hollow tube at its first and second ends is larger than an inside diameter of a human blood vessel and wherein when the blend is exposed to physiological conditions the hollow tube swells, such that when the device is implanted to at least one end of the human blood vessel, the device provides securing or sealing to fluid flow.

2. The anastomosis device according to claim 1 , further comprising at least one non-piercing suture adapted to be wrapped around the at least one end of the human blood vessel to secure it to the hollow tube.

3. The anastomosis device according to claim 1 , wherein at least one the ends of the hollow tube further comprises a spherical enlarged portion.

4. The anastomosis device according to claim 1 , wherein the first end of the hollow tube includes at least one barb extending substantially transverse to the longitudinal axis of the hollow tube and adapted to penetrate at least a portion of the human blood vessel; and the device further comprising a first sleeve adapted to fit over the human blood vessel when the human blood vessel is fitted over the first end of the hollow tube and penetrated by the at least one barb to capture the human blood vessel between the first end and the first sleeve.

5. The anastomosis device according to claim 1 , wherein the blend further comprises an additive.

6. The anastomosis device according to claim 1 , wherein the hollow tube is or comprises a cylindrical body portion that is a multilayered cylindrical body portion.

7. The anastomosis device according to claim 1 , wherein the hollow tube is or comprises a cylindrical body portion that has an average mechanical stiffness of 1.2 kN/m.

8. The anastomosis device according to claim 1 , wherein the hollow tube is or comprises a cylindrical body portion that has an average radial strength of 300 mmHg.

9. The anastomosis device according to claim 1 , wherein the blend comprises micropores.

10. The anastomosis device according to claim 1 , wherein the blend further comprises an active agent.

11. The anastomosis device according to claim 1 , wherein the blend further comprises an anti-restenosis agent.

12. A method comprising:

implanting the anastomosis device of claim 1 at a target site in a subject.

13. The method of claim 12 , wherein the hollow tube based blend material swells upon implantation at the target site, thereby reducing anastomosis device malapposition post-implantation.

14. The method of claim 12 , wherein the anastomosis device degrades as a tissue surrounding the target site remodels or regenerates.

15. A cell scaffold comprising the anastomosis device of claim 1 , wherein the plasticizer is glycerol and the blend further comprises a cell.

16. A method for joining a first human blood vessel to a second human blood vessel, the method comprising steps of:

providing the anastomosis device of claim 1 ;

inserting the first end of the hollow tube into a terminal end of a first human blood vessel and the second end of the hollow tube into a terminal end of a second human blood vessel.

17. The method according to claim 16 , further comprising wrapping a non-piercing suture around at least one of the first human blood vessel and the second human blood vessel to secure at least one of the first human blood vessel and the second human blood vessel to the hollow tube.

18. The method according to claim 16 , further comprising a step of positioning an outer sleeve over the first end of the hollow tube after the first end of the hollow tube has been inserted into the terminal end of the first human blood vessel to capture the first human blood vessel between an outside diameter of the first end of the hollow tube and an inside diameter of the outer sleeve.

19. The anastomosis device according to claim 1 , wherein at least one of the first end and the second end is beveled.

20. The anastomosis device according to claim 1 , wherein an outer surface of at least one of the ends of the hollow tube further comprises threads, wherein the device further comprises at least one spherical enlarged portion having threads adapted to receive the threads from the at least one of the ends of the hollow tube, and wherein when the spherical enlarged portion is inserted into the end of the human blood vessel it is configured to be screwed onto threading of the spherical enlarged portion.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 4, 2017
From: TUFTS UNIVERSITY BOSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041239/0603 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2016
From: IBRAHIM, AHMED; LIN, SAMUEL
To: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
Reel/Frame 038488/0743 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2016
From: JOSE, RODRIGO R.; RAJA, WASEEM K.; KAPLAN, DAVID L.; ABDURROB, ABDURRAHMAN
To: TRUSTEES OF TUFTS COLLEGE
Reel/Frame 038488/0774 →
Continuity (2)
Provisional Application 61815551 · Apr 24, 2013
Related Publication 20160095599A1 · Apr 7, 2016